tate dehydrogenase concentration. Conclusions: Increased conjunctival V is associated with albuminuria in SCD subjects. Assessment of conjunctival microvascular hemodynamics may improve our understanding of the pathophysiology and clinical management of sickle cell nephropathy.
Introduction
Sickle cell disease (SCD) is among the most common monogenetic diseases in the United States and is characterized by the formation of rigid, sickle shaped erythrocytes [1] . Sickle cell nephropathy (SCN) is a well-known cause of morbidity and mortality in SCD subjects [2] , with structural and functional abnormalities throughout the nephron [3, 4] . An early sign of SCN is hyperfiltration, which presents with increased renal blood flow and glomerular filtration rate (GFR). Persistently elevated GFR in SCD subjects can be a precursor of glomerular damage and sclerosis, which may lead to progressive renal insufficiency [3, 5, 6] . While glomerular damage is progressing, there is a switch from hyperfiltration to a normal GFR and then a reduced GFR [7, 8] . Albuminuria is a hallmark of early kidney damage in SCD, and often occurs before the GFR decreases to below the normal range [9] .
Early detection of renal dysfunction in SCD subjects is problematic, in part due to an inaccurate estimation of GFR in SCD subjects [10] , and the presence of albuminuria even in individuals with apparently preserved GFR [11, 12] . Albuminuria may be associated with a rapid progression to worsening renal dysfunction [13] . Once endstage renal disease is reached, there is a marked increase in the mortality rate of those with SCD [14] . Previous studies have investigated clinical factors associated with proteinuria in SCD, including older age [9, 15] , increased blood pressure [16] , low hemoglobin levels [7] , hemolysis [17] , leukocytosis [18] , absence of α-thalassemia [19] and stroke [18] . Nevertheless, these factors do not fully account for all the heterogeneity associated with albuminuria in SCN, and factors associated with proteinuria in the subjects with preserved GFR are not well understood.
SCD is a systemic vascular disease [20] . Events originating elsewhere in SCD subjects can target the kidney, and the kidney, in turn, can engage in long-range signaling to distant organs and tissues [21] [22] [23] . Furthermore, microvascular hemodynamics in the conjunctiva have been shown to be sensitive to the systemic severity of disease [24] and are altered in other SCD complications including stroke [25] , and sickle cell retinopathy [26] . Although the conjunctival microcirculation has been assessed in SCD subjects [27] [28] [29] [30] , to our knowledge, there are no published data regarding the microvascular hemodynamic properties in relation to kidney function in SCD subjects with preserved GFR. The purpose of the current study was to determine the association between conjunctival hemodynamic properties and albuminuria in SCD subjects with preserved GFR.
Patients and Methods

Subjects
This research study was approved by an Institutional Review Board of the University of Illinois at Chicago. Prior to subject enrollment, the research study was explained to the subjects, and informed consents were obtained according to the tenets of the Declaration of Helsinki. Ten healthy African-American control subjects (1 man and 9 women) without a history of cerebrovascular, hypertension or ocular diseases and 35 subjects (14 men and 21 women) with a clinical diagnosis of sickle cell anemia (SS 32, Sβ 0 -thalassemia 3) participated in this study. Only SCD subjects with estimated GFR (eGFR) ≥ 60 ml/min/1.73 m 2 were included, which corresponds to stages 0, 1 and 2 of the Kidney Disease Outcomes Quality Initiative (KDOQI) classification of chronic kidney disease [31] . The exclusion criteria for SCD subjects were a history of blood transfusion within 2 months prior to imaging, <2 urine samples to define albuminuria status, diagnosis of diabetes mellitus and dry eye syndrome or use of local sympathomimetic or para-sympatholytic medications prior to conjunctival imaging. The majority of SCD subjects (n = 28) who participated in the study were those from our previous published studies [26, 30, 32, 33] .
Clinical data including the subject's age, sex, body mass index (BMI) and history of hydroxyurea (HU) treatment were obtained from the clinical charts. Laboratory data including hematocrit (HCT), reticulocyte (Ret), white blood cell (WBC), neutrophil and platelet (PLT) counts and lactate dehydrogenase (LDH) levels within 3 months of imaging were recorded. Fetal hemoglobin (HbF) data were recorded within 6 months of imaging. Systolic and diastolic blood pressure (SBP and DBP, respectively) were measured either at the time of imaging (7 of 35 subjects) or within a few hours of imaging during the subject's clinic visit (28 of 35 subjects). The mean SBP and DBP were then converted to mean arterial blood pressure (MAP) using a standard formula: MAP = 1/3(SBP) + 2/3(DBP). BMI was defined as weight in kilograms divided by the square of the height in meters squared. Alpha thalassemia status was determined by multiplex PCR, as previously described [34] , and was available in 24 of 35 SCD subjects.
Definition of Albuminuria
Clinical markers of renal function were obtained from the inpatient or outpatient clinical charts, and included albumin excretion ratio (AER), serum creatinine (Cr) level and eGFR. The median time interval between the renal test and conjunctival imaging was 4 months (interquartile range 2-6 months), and in the majority of subjects (30 out of 35), the time interval was within 6 months of imaging. AER category was defined as normoalbuminuria (AER <30 mg/g creatinine), microalbuminuria (AER = 30-300 mg/g creatinine) or macroalbuminuria (AER ≥ 300 mg/g creatinine). The presence of microalbuminuria and macroalbuminuria was confirmed in at least 2 consecutive random urine samples. The eGFR was determined from the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation 1 [35] , which is the preferred equation to determine the eGFR in adult SCD subjects [36] 
where Cr is serum creatinine (mg/dl), κ is 0.7 for females and 0.9 for males, α is -0.329 for females and -0.411 for males, min indicates the minimum of Cr/κ or 1 and max indicates the maximum of Cr/κ or 1. The latter 2 coefficients in the equation (1.018 and 1.159) are considered to be 1 if the subject is not female or not African-American, respectively.
Conjunctival Microcirculation Imaging
Imaging of the conjunctival microcirculation was performed with our previously described optical imaging system (EyeFlow TM ) [37] . The imaging system, comprising a slit lamp biomicroscope and a digital charged coupled device camera (Photometrics, Tuscon, Ariz., USA), was used to acquire image sequences of red blood cell movement within the conjunctiva microcirculation at high magnification. An external fixation target was presented to the subjects to minimize eye movement and several 2-s image sequences were acquired. In each image sequence, ≥ 10 consecutive frames were manually selected for analysis based on image focus and the absence of large eye movements.
Our method for deriving conjunctival hemodynamic properties has been previously described and was validated [26, 30, [37] [38] [39] . Briefly, image sequences were first registered to correct for eye 489 movement, then hemodynamic measures of conjunctival diameter (D) and axial blood velocity (V) were derived for several selected conjunctival venules. To determine conjunctival D, a centerline of a manually selected venule was automatically extracted, and D was calculated as the average full width at half maximum of intensity profiles generated perpendicular to the vessel centerline along the vessel length. Conjunctival V was assessed by measuring the movement of red blood cells along the vessel centerline in consecutive frames using spatial-temporal images. These images displayed intensity variation along the centerline of the vessel (rows) as a function of time (columns), revealing diagonal bands corresponding to the motion of aggregated red bloods cells (or plasma gaps). Conjunctival V was derived by determining the slope of the prominent bands [37, 38] . Venules were distinguished from arterioles by visualizing the motion of red blood cells within the vessel and determining whether blood drained into another vessel (venule) or diverged into vessel branches (arteriole). Hemodynamic measurements were obtained in venules because they are more frequent, have less pulsatility [40, 41] and have higher contrast compared to arterioles. The individuals who performed conjunctival imaging and image analysis were masked to the renal status of the subjects.
The median number of venules that were analyzed in each subject was 11 venules (interquartile range [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Conjunctival D and axial V measurements were obtained in a total of 179 and 432 conjunctival venules of 10 control and 35 SCD subjects. Mean conjunctival D and V were calculated in each subject for further statistical analysis.
Statistical Analysis
According to the 95% CI of mean conjunctival V (0.40-0.60 mm/s) in control subjects, SCD subjects were categorized to 1 of 3 V groups: V1, <0.40 mm/s; V2, 0.40-0.60 and V3, >0.60 mm/s. A one-way analysis of variance, post hoc and contrast analyses were performed to compare differences and linear trends of continuous variables among V groups. Categorical variables were compared using the chi-square test. First, the Pearson correlation coefficient was computed to assess the relationship between albuminuria and continuous variables including conjunctival D and V and demographic and clinical data. Then, variables with a p ≤ 0.2 on univariate analysis (conjunctival V, HCT, WBC and LDH) and traditionally known risk factors (age, MAP and α-globin deletions) were included in the multiple linear regression analysis after testing for collinearity among independent variables. In the case of collinear relationships among independent variables (HCT, WBC, α-globin deletions with LDH), only one variable was included in the final multiple linear regression analysis. For correlation and the multiple linear regression analyses, albuminuria was log-transformed to approximate a normal distribution. Continuous variables were shown as means ± SD or means ± SEM. Statistical analysis was performed using SPSS, version 22 (SPSS Inc., Chicago, Ill., USA). The post hoc statistical power for the correlation between conjunctival V and albuminuria was calculated using G * Power, version 3.1 [42] . Statistical significance was accepted at p < 0.05 for regression analyses.
Results
Clinical Correlates and Albuminuria
The mean ± SD age of the control (38 ± 11 years, n = 10) and SCD subjects (35 ± 12 years, n = 35) was similar (p = 0.5). SBP was not significantly different between control (124 ± 14 mm Hg, n = 5) and SCD subjects (121 ± 15; p = 0.7), while DBP in SCD subjects (69 ± 10 mm Hg) was significantly lower than in control subjects (78 ± 5 mm Hg; p = 0.04). Twenty subjects had normoalbuminuria, 10 subjects had microalbuminuria and 5 subjects had macroalbuminuria. AER did not correlate significantly with age, SBP, DBP, BMI, HCT, HbF, Ret, WBC, neutrophil, PLT, serum Cr or eGFR (p ≥ 0.1). Table 1 summarizes demographic and clinical data of SCD subjects stratified by conjunctival V. There was not a significant difference in age, sex, SBP, DBP, MAP, BMI, HU treatment, HCT, HbF, Ret, WBC, neutrophil, PLT, LDH, serum Cr or eGFR among V groups (p ≥ 0.2).
Microvascular Hemodynamics and Albuminuria
Mean ± SEM AER measurements in the V1, V2 and V3 groups were 30 ± 17, 68 ± 31 and 475 ± 232 mg/g creatinine, respectively. Mean ± SD of conjunctival D and V and log(AER) measurements in V groups are summarized in table 2 . Mean conjunctival D measurements were not significantly different among the V groups (p = 0.3) while, by definition, the mean conjunctival V measurements were different (p < 0.001). Mean log(AER) measurements differed significantly among the V groups and followed a positive linear trend from the V1 to V3 groups (p = 0.01). Mean log(AER) was significantly higher in the V3 group than in the V1 (p = 0.01) and V2 (p = 0.04) groups. Mean log(AER) were not statistically different between the V1 and V2 groups (p = 0.3). Figure 1 displays the relationship between albuminuria and conjunctival V in SCD subjects. There was not a significant correlation between conjunctival D and albuminuria (r = 0.08, p = 0.7), while conjunctival V correlated significantly with albuminuria (r = 0.47, p = 0.005). As summarized in table 3 , in the multiple linear regression analysis conjunctival V independently correlated with albuminuria (p = 0.01), after adjusting for age, MAP, α-globin deletions, HCT, WBC and LDH values. LDH correlated independently with albuminuria (p = 0.04).
Discussion
SCD subjects with preserved eGFR may develop albuminuria [11, 12] , indicating a deterioration in renal function [10] . There is little information about the microvascular hemodynamic properties in SCD subjects with preserved eGFR. In this study, we found that SCD subjects with preserved eGFR and higher than normal conjuncti-val V had a greater degree of albuminuria as compared with subjects with preserved eGFR and normal or lower than normal conjunctival V. Furthermore, conjunctival V independently correlated with albuminuria in SCD subjects with preserved eGFR.
The exact mechanism responsible for the correlation between conjunctival V and albuminuria in SCD subjects with preserved GFR is unclear, although a previously described 'perfusion paradox' in SCD subjects may in part account for these findings [21] [22] [23] . In general, the perfusion paradox in SCD is characterized by contrasting perfusion profiles in the local and systemic circulations: hypoperfusion in the local microcirculatory beds occluded by HbS-containing erythrocytes but hyperperfusion in the systemic circulation and a number of regional vasculatures [23] . The perfusion paradox is also believed to happen in SCN [21] [22] [23] . Preserved GFR in subjects in this study might be a sign of cortical hyperperfusion, which was likely a manifestation of systemic hyperperfusion [22] . This presumed systemic hyperperfusion may in part account for increased microvascular conjunctival V, as seen in our subjects. The systemic hyperperfusion in SCD subjects without major organ complication has been attributed to higher plasma volume and cardiac output [43, 44] and diminished systemic vascular resistance [43, 45] , indicating increased blood V as documented in organs other than the conjunctiva including the forearm [46] , pedal cutaneous area [47] and kidney [48] . Moreover, since cardiac output is higher than normal in SCD subjects due to anemia, the decreased DBP in SCD subjects compared to control subjects is also consistent with presumed reduced systemic vascular resistance, and thereby systemic hyperperfusion. Future studies are needed to directly investigate the association between cardiac output, systemic vascular resistance and conjunctival hemodynamics in SCD subjects. Data are reported as mean ± SD or number (percentage). HbF data were not available in 2, 3 and 1 subjects in V1, V2 and V3 groups, respectively.
In this study, conjunctival V was associated with albuminuria in SCN, independent of previously reported factors associated with renal function including age [9, 15] , blood pressure [16] , α-globin microdeletions [19] , HCT [7] , hemolysis [17, 49] and leukocytosis [18] . There are multiple pathways for damage to the nephron in SCD including hyperfiltration, hypertension, ischemia from vaso-occlusion, hemolysis-related vasculopathy and chronic cell-free hemoglobin exposure [22] . Albuminuria reflects damage to the glomerulus and may be an early marker of kidney disease and may precede a decline in the eGFR. Our finding of an increased conjunctival V correlating with the degree of albuminuria is consistent with the model of a high flow state, such as hyperfiltration, contributing to earlier stages of glomerular damage and SCN.
Although some SCD subjects with low and normal conjunctival V had microalbuminuria, increased conjunctival V measurements tended to be found in subjects with macroalbuminuria. Measuring the conjunctival V may allow clinicians to develop a more intensive personalized management strategy including an emphasis on preventative care. Future longitudinal studies with a larger population are needed to determine the predictive value of increased conjunctival V for development of albuminuria.
The retrospective nature and small sample size were limitations of the current study. Using conjunctival V and albuminuria measurements and the number of subjects in the present study, the statistical power was calculated to be 0.85 at a significance level of 0.05, indicating sufficient sample size to detect correlation between 2 variables. The clinical renal function tests were performed close to the conjunctival imaging (median time 4 months), thus reducing the potential for variations in renal function markers between the time of imaging and data collection. Conjunctival V measurements in normal subjects in the present study were lower than what has been reported in a previous study [50] , which may be attributed to AfricanAmerican origin and larger age range of the control subjects, and to different measurement techniques. Random urine samples were used to define albuminuria which may be a limitation, although determination of albuminuria status was confirmed on 2 consecutive urine samples. Though most available methods are limited for determination of GFR in SCD subjects [51, 52] , we used the CKD-EPI equation [35] , which is particularly accurate for the estimation of high GFR values, including glomerular hyperfiltration in SCD subjects [36] .
In summary, increased conjunctival V is associated with albuminuria in sickle cell subjects. Assessment of conjunctival microvascular hemodynamics may help improve our understanding of the pathophysiology and clinical management of SCN.
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